ANGPTL8 and metabolic disease: Some studies reported increased circulating betatrophin levels in patients with type 2 diabetes mellitus (T2DM) [15–20] and obesity [15, 21, 22], whereas others found no difference [23, 24] or even a decrease [25] in these metabolic disorders.